WallStreet Performers of the Day: Copart, Inc. (NASDAQ:CPRT), Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

Copart, Inc. (NASDAQ:CPRT)

The shares of Copart, Inc. (NASDAQ:CPRT) started off the last trading session with the price of $45.63 while closing the day with the price of $46.16. The shares of Copart, Inc. (NASDAQ:CPRT) Rise 0.46% with the Gain of 0.53 points.

The shares of Copart, Inc. (NASDAQ:CPRT) traded with the day volume of 1.36 Million shares whereas its average trading volume is 1.29 Million.

While analyzing the past performance of the stock we can see that the shares of Copart, Inc. (NASDAQ:CPRT) Loss -1.3% in the last week while rising 4.74% in the last month. Past quarter performance shows the green light with 9.57%. The semi-annual and annual performance shows 44.79% and 53.56% respectively.

Some critical values of the shares of Copart, Inc. (NASDAQ:CPRT) to be discussed here are: the beta which shows the value at 1.03 while Average True Range of Copart, Inc. (NASDAQ:CPRT) demonstrate the value at 1.35. The weekly and monthly volatility of the shares of Copart, Inc. (NASDAQ:CPRT) are indicated at 3.98% and 3.31%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 57.15.

While studying the financial position of the shares of Copart, Inc. (NASDAQ:CPRT), we can see that the Market capitalization of the company is at 10.63 Billion. The shares outstanding for the company is 230.25 Million and the shares float stands at 200.78 Million. The income of the company stand at 351.7 Million while the sales stand at 1.63 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.47, Price to Earnings or P/E is at 31.36, Price to Sales P/S show the value of 6.52, the Return on Asset ROA stood at 0.171 and the Return on Equity ROE depicted at 0.296 while Return on Investment ROI is at 0.24.


Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH)

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) started its previous trading session at $2.65 and closed at $2.64 showing a Fell of -1.86 Percent.

The Company traded with an average Volume of 1.34 Million whereas, its Day Volume stood at 1.22 Million.

Looking at the performance of the stock, Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) Gain 20% in the last week in its shares price and -54.79% in the last month. Quarterly performance shows a red of -59.07 Percent while Semi-Annual and Annual performances shows a -61.79 and -56.65 percent respectively.

Beta for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) stands at 2.75 while the ATR (average true range) is at 0.39. The Stock’s Weekly and Monthly Volatility is 15.71% and 10.26% respectively showing a RSI value of 32.01.

While studying the financial position of the shares of Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), we can see that the Market capitalization of the company is at 138.81 Million. The shares outstanding for the company is 52.58 Million and the shares float stands at 51.52 Million.

The Company generated an income of -113700000 and the sales of 8.2 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.87 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 16.93 respectively.

The Return on Assets stands at -0.775, ROE shows a value of -0.883 and ROI for Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) is -0.556 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment